Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients.

Different highly effective interferon-free treatment options for chronic hepatitis C virus (HCV) infection are currently available. Pre-existence of resistance associated variants (RAVs) to direct antiviral agents (DAAs) reduces sustained virologic response (SVR) rates by 3-53% in hepatitis C virus...

全面介紹

書目詳細資料

Principais autores:	Julia Dietz, Simone Susser, Caterina Berkowski, Dany Perner, Stefan Zeuzem, Christoph Sarrazin
格式:	Artigo
語言:	Inglês
出版:	Public Library of Science (PLoS) 2015-01-01
叢編:	PLoS ONE
在線閱讀:	https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0134395&type=printable
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!